Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Top Cited Papers
- 25 September 2008
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 359 (13), 1317-1329
- https://doi.org/10.1056/nejmoa0804656
Abstract
Intravenous thrombolysis with alteplase is the only approved treatment for acute ischemic stroke, but its efficacy and safety when administered more than 3 hours after the onset of symptoms have not been established. We tested the efficacy and safety of alteplase administered between 3 and 4.5 hours after the onset of a stroke.This publication has 23 references indexed in Scilit:
- Shift Analysis Versus Dichotomization of the Modified Rankin Scale Outcome Scores in the NINDS and ECASS-II TrialsStroke, 2007
- CorrectionStroke, 2007
- Guidelines for the Early Management of Adults With Ischemic StrokeStroke, 2007
- The rtPA (Alteplase) 0- to 6-Hour Acute Stroke Trial, Part A (A0276g)Stroke, 2000
- Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic StrokeStroke, 1997
- Use of a Global Test for Multiple Outcomes in Stroke Trials With Application to the National Institute of Neurological Disorders and Stroke t-PA Stroke TrialStroke, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeThe New England Journal of Medicine, 1995
- Measurements of acute cerebral infarction: a clinical examination scale.Stroke, 1989
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988
- ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical ScaleThe Lancet, 1975